| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer
|
Macdonald, G.
|
|
|
16 |
9 |
p. 1442-1448
|
article
|
| 2 |
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801)
|
Bouché, O.
|
|
|
16 |
9 |
p. 1488-1497
|
article
|
| 3 |
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process
|
Demicheli, R.
|
|
|
16 |
9 |
p. 1449-1457
|
article
|
| 4 |
Chemotherapy dose intensity in non-Hodgkin's lymphoma: is dose intensity an emerging paradigm for better outcomes?
|
Gregory, S.A.
|
|
|
16 |
9 |
p. 1413-1424
|
article
|
| 5 |
Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan
|
Huang, S.-Y.
|
|
|
16 |
9 |
p. 1530-1538
|
article
|
| 6 |
Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors
|
Segaert, S.
|
|
|
16 |
9 |
p. 1425-1433
|
article
|
| 7 |
Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET?
|
Reinhardt, M.J.
|
|
|
16 |
9 |
p. 1524-1529
|
article
|
| 8 |
Cyclooxygenase inhibitors may be more effective in hormone-dependent endometrial cancers: interaction between cyclooxygenase and aromatase
|
Altundag, K.
|
|
|
16 |
9 |
p. 1559
|
article
|
| 9 |
Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications
|
Italiano, A.
|
|
|
16 |
9 |
p. 1503-1507
|
article
|
| 10 |
Epirubicin, cisplatin and docetaxel combination therapy for metastatic gastric cancer
|
Di Lauro, L.
|
|
|
16 |
9 |
p. 1498-1502
|
article
|
| 11 |
ESMO at 30: Mission ongoing
|
Kosmidis, P.A.
|
|
|
16 |
9 |
p. 1411-1412
|
article
|
| 12 |
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma
|
Mikhaeel, N.G.
|
|
|
16 |
9 |
p. 1514-1523
|
article
|
| 13 |
High-dose mitoxantrone–vinblastine–cyclophosphamide and autologous stem cell transplantation for stage III breast cancer: final results of a prospective multicentre study
|
Stewart, D.A.
|
|
|
16 |
9 |
p. 1463-1468
|
article
|
| 14 |
History of cirrhosis and risk of digestive tract neoplasms
|
Randi, G.
|
|
|
16 |
9 |
p. 1551-1555
|
article
|
| 15 |
Impact of EGFR expression on colorectal cancer patient prognosis and survival: a response
|
Repetto, L.
|
|
|
16 |
9 |
p. 1557
|
article
|
| 16 |
In this issue
|
|
|
|
16 |
9 |
p. 1405
|
article
|
| 17 |
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer
|
Alliot, C.
|
|
|
16 |
9 |
p. 1559-1560
|
article
|
| 18 |
In vivo chemosensitivity adapted preoperative chemotherapy in patients with early stage breast cancer: the Gepartrio pilot study
|
von Minckwitz, G.
|
|
|
16 |
9 |
p. 1560-1561
|
article
|
| 19 |
Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study
|
Montalban, C.
|
|
|
16 |
9 |
p. 1539-1544
|
article
|
| 20 |
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2)
|
Chua, S.
|
|
|
16 |
9 |
p. 1435-1441
|
article
|
| 21 |
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes
|
Cocconi, G.
|
|
|
16 |
9 |
p. 1469-1476
|
article
|
| 22 |
Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems
|
Perea, G.
|
|
|
16 |
9 |
p. 1508-1513
|
article
|
| 23 |
Quality-adjusted survival in a crossover trial of letrozole versus tamoxifen in postmenopausal women with advanced breast cancer
|
Irish, W.
|
|
|
16 |
9 |
p. 1458-1462
|
article
|
| 24 |
Relevance of EGFR expression in colorectal cancer
|
Alliot, C.
|
|
|
16 |
9 |
p. 1557-1558
|
article
|
| 25 |
Reply to the “Letter to the Editor on ‘Relevance of EGFR expression in colorectal cancer’” by C. Alliot (Ann Oncol 2005; 16: 1557)
|
Spano, J.P.
|
|
|
16 |
9 |
p. 1558-1559
|
article
|
| 26 |
Retinoid receptors in ovarian cancer: expression and prognosis
|
Kaiser, P.C.
|
|
|
16 |
9 |
p. 1477-1487
|
article
|
| 27 |
Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment †
|
Shafqat, A.
|
|
|
16 |
9 |
p. 1545-1550
|
article
|
| 28 |
‘Small’ randomised neo-adjuvant chemotherapy trials in breast cancer reporting on pathological response: more harm than good?
|
Bonnefoi, H.
|
|
|
16 |
9 |
p. 1407-1410
|
article
|
Journal description